Médicament 📍 BR

COMB ISO

43,56 R$

Prix max. consommateur (CMED)

Analogs of COMB ISO

Find cheaper analogs and generic equivalents for COMB ISO.

Buy now on Amazon Search results on Amazon.ca — as an Amazon Associate we earn from qualifying purchases.

Ingredients

Principe actif : ferripolimaltose

Aperçu du produit

About COMB ISO

COMB ISO is a prescription medication formulated to support iron metabolism and improve overall iron status in patients with iron deficiency. The product contains the active ingredient ferripolimaltose, a complex iron chelate that is designed to enhance absorption and reduce gastrointestinal irritation compared with conventional iron salts. COMB ISO is manufactured under strict quality control standards and is available in tablet form for oral administration. The medication is intended for use under the supervision of a qualified healthcare professional and is not suitable for self‑medication.

Key Benefits & Uses

Improves iron absorption and bioavailability.
Reduces the risk of gastrointestinal side effects such as nausea and constipation.
Supports the restoration of normal hemoglobin levels in iron‑deficient patients.

Active Ingredient & Action

The active component, ferripolimaltose, is a polymeric iron complex that releases iron ions in a controlled manner. This mechanism allows for a steady supply of iron to the bloodstream, facilitating the synthesis of hemoglobin and other iron‑dependent proteins. By minimizing peak concentrations of free iron, ferripolimaltose helps to lower oxidative stress and improve tolerability.

Important Notes

COMB ISO should be taken with food or a full glass of water to further reduce the likelihood of stomach upset. Patients should avoid taking the medication concurrently with high‑dose calcium supplements or antacids, as these can interfere with iron absorption. Regular monitoring of blood iron levels and complete blood count is recommended to assess treatment efficacy and adjust dosing as needed. Discontinue use and consult a healthcare provider if symptoms of iron overload, such as abdominal pain, vomiting, or jaundice, occur. COMB ISO is not indicated for individuals with hemochromatosis or other conditions that predispose to iron overload. The medication is contraindicated in patients with known hypersensitivity to any component of the formulation.